These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15324938)

  • 21. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes.
    Hnatyszyn HJ
    Antivir Ther; 2005; 10(1):1-11. PubMed ID: 15751759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of chronic hepatitis C in veterans: the potential of integrated care models.
    Ho SB; Groessl E; Dollarhide A; Robinson S; Kravetz D; Dieperink E
    Am J Gastroenterol; 2008 Jul; 103(7):1810-23. PubMed ID: 18564122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance of patients with chronic hepatitis C not on antiviral therapy: a practical approach.
    Puoti C; Bellis L; Martellino F; Durola L; Galossi A; Guarisco R; Dell' Unto O
    Rom J Gastroenterol; 2005 Jun; 14(2):141-6. PubMed ID: 15990933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recurrence of hepatitis C virus (HCV) infection after liver transplantation for HCV-related disease: host factors and viral factors implicated in the occurrence and the severity of HCV recurrence].
    Schvoerer E; Thumann C; Soulier E; Royer C; Fafi-Kremer S; Brignon N; Ellero B; Woehl-Jaegle ML; Meyer C; Wolf P; Jaeck D; Stoll-Keller F
    Pathol Biol (Paris); 2006 Dec; 54(10):556-60. PubMed ID: 17027191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Monitoring patients with chronic hepatitis during and after therapy].
    Colić-Cvrlje V
    Acta Med Croatica; 2005; 59(5):413-7. PubMed ID: 16381236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic hepatitis C in the Hispanic/Latino population living in the United States: a literature review.
    Blessman DJ
    Gastroenterol Nurs; 2008; 31(1):17-25; quiz 26-7. PubMed ID: 18300820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The program of early detection of HCV infection].
    Borzecka B; Błudzin W
    Przegl Epidemiol; 2007; 61(4):733-8. PubMed ID: 18572505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient concerns regarding chronic hepatitis C infections.
    Minuk GY; Gutkin A; Wong SG; Kaita KD
    J Viral Hepat; 2005 Jan; 12(1):51-7. PubMed ID: 15655048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic hepatitis C infection in children.
    Broide E; Kimchi NA; Scapa E
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):187-93. PubMed ID: 16557189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.
    Buti M; San Miguel R; Brosa M; Cabasés JM; Medina M; Angel Casado M; Fosbrook L; Esteban R
    J Hepatol; 2005 May; 42(5):639-45. PubMed ID: 15826711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of recurrent hepatitis C after liver transplantation.
    Biggins SW; Terrault NA
    Clin Liver Dis; 2005 Aug; 9(3):505-23, ix. PubMed ID: 16023980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
    Ueno Y; Sollano JD; Farrell GC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus (HCV) infection: a systemic disease.
    Craxì A; Laffi G; Zignego AL
    Mol Aspects Med; 2008; 29(1-2):85-95. PubMed ID: 18177700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of anti-hepatitis C virus antibodies in pregnant women and their offspring in a tertiary hospital in Southwestern Nigeria.
    Ogunro PS; Adekanle DA; Fadero FF; Ogungbamigbe TO; Oninla SO
    J Infect Dev Ctries; 2007 Dec; 1(3):333-6. PubMed ID: 19734615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
    Chakravarti A; Verma V; Jain M; Kar P
    Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.